MASI Masimo Corporation
Healthcare$178.81+0.10%ClosedMarket Cap: $9.36B
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
11.83
P/S
6.01
EV/EBITDA
28.23
DCF Value
$30.47
FCF Yield
2.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
61.7%
Operating Margin
19.9%
Net Margin
4.9%
ROE
9.1%
ROA
4.6%
ROIC
18.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $403.6M | 62.1% | $77.4M | $57.1M | $— | — |
| Q4 null | $412.5M | 60.0% | $83.9M | $68.3M | $— | — |
| FY null | $1.53B | 61.9% | $312.8M | $-151.5M | $— | — |
| Q3 null | $371.5M | 62.1% | $83.6M | $-100.4M | $— | — |
| Q2 null | $370.9M | 62.9% | $64.5M | $51.3M | $— | — |
| Q1 null | $372.0M | 62.9% | $78.0M | $-170.7M | $— | — |
| Q4 null | $600.7M | 40.7% | $-359.1M | $-349.6M | $— | — |
| FY null | $2.09B | 48.0% | $-266.7M | $-304.9M | $— | — |
| Q3 null | $504.6M | 52.2% | $30.1M | $9.8M | $— | — |
| Q2 null | $343.9M | 60.3% | $41.9M | $16.0M | $— | — |
| Q1 null | $339.6M | 60.8% | $53.1M | $18.9M | $— | — |
| Q4 2023 | $548.9M | 47.9% | $44.0M | $33.9M | $0.63 | — |